Mark James Daniel insider trades

Open-market stock purchases and sales by Mark James Daniel, Chief Financial Officer at Atossa Therapeutics, Inc, from SEC Form 4 filings since Oct 14, 2025.

Recent trades

DateStockTradeValue
Mar 26, 2026ATOS Atossa Therapeutics, IncBought (not open market)—
Oct 14, 2025ATOS Atossa Therapeutics, IncBought (not open market)—

Companies traded

  • ATOS Atossa Therapeutics, Inc: other filings, last Mar 26, 2026

Get free alerts when Mark James Daniel files a new trade →